ImmuCell Corporation (ICCC) vs Park Dental Partners, Inc. Common Stock (PARK)

A side-by-side comparison of ImmuCell Corporation and Park Dental Partners, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ICCC vs PARK

growth of $100 · dividends reinvested · last 1y
ICCC +108.3% (+108.3%/yr)PARK +105.8% (+105.8%/yr)ICCC compounded faster over this window
100150200250Start $1002026$208$206
ICCC PARK

ICCC vs PARK: by the numbers

  • •PARK is the larger company ($93M vs $89M market cap).
  • •ICCC is profitable (2.57% net margin) while PARK runs a net loss (-1.41%).

Metrics side by side

Valuation

MetricICCCPARK
P/E ratio116.73N/A
Forward P/EN/A12.47
P/S ratio2.910.37
P/B ratio2.853.13
EV / EBITDA14.87N/A
FCF yield4.72%5315.42%

Profitability

MetricICCCPARK
Gross margin40.32%10.89%
Operating margin12.60%-2.82%
Net margin2.57%-1.41%
ROE2.51%-11.85%
ROIC8.16%-4.43%

Growth (annualized)

MetricICCCPARK
Revenue CAGR (5Y)13.74%N/A
Total return CAGR (5Y)0.65%N/A

Frequently asked

Is ICCC or PARK more profitable?
ICCC runs the higher net margin — ICCC at 2.57% versus PARK at -1.41%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.